← All trials
NCT05961527
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2023
- Primary completion
- Jul 31, 2025
- Completion date
- Sep 30, 2025
- First posted
- Jul 27, 2023
- Last posted
- Nov 18, 2023
- Enrollment
- 18
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Department of Veteran AffairsLead sponsor
- Oregon Health and Science UniversityReponsible party - principal investigator
- Steven & Alexandra Cohen Children's Medical Center, New YorkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.